PDZRN3
Basic information
Region (hg38): 3:73382431-73624941
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDZRN3 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 5 | |||||
missense | 66 | 69 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 0 | |||||
non coding | 1 | |||||
Total | 0 | 1 | 66 | 4 | 5 |
Variants in PDZRN3
This is a list of pathogenic ClinVar variants found in the PDZRN3 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-73383541-C-T | not specified | Uncertain significance (May 15, 2024) | ||
3-73383716-G-C | not specified | Uncertain significance (Aug 22, 2023) | ||
3-73383718-T-C | not specified | Uncertain significance (Oct 25, 2023) | ||
3-73383781-C-T | not specified | Uncertain significance (Mar 25, 2024) | ||
3-73383811-T-C | not specified | Uncertain significance (Apr 06, 2024) | ||
3-73383831-G-A | not specified | Uncertain significance (Jan 10, 2023) | ||
3-73383831-G-T | not specified | Uncertain significance (Nov 14, 2023) | ||
3-73383907-T-C | not specified | Uncertain significance (Jul 26, 2022) | ||
3-73383933-T-C | not specified | Uncertain significance (Mar 04, 2024) | ||
3-73383948-A-G | not specified | Uncertain significance (Apr 26, 2023) | ||
3-73383995-G-T | not specified | Uncertain significance (Oct 03, 2022) | ||
3-73383996-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
3-73384007-C-G | not specified | Uncertain significance (Apr 07, 2022) | ||
3-73384017-G-T | not specified | Uncertain significance (May 03, 2023) | ||
3-73384023-C-A | not specified | Uncertain significance (Jun 24, 2022) | ||
3-73384027-G-A | not specified | Uncertain significance (Jan 26, 2022) | ||
3-73384028-G-C | not specified | Uncertain significance (Feb 03, 2022) | ||
3-73384038-C-T | not specified | Uncertain significance (Mar 18, 2024) | ||
3-73384047-C-A | not specified | Uncertain significance (Feb 05, 2024) | ||
3-73384054-T-C | not specified | Uncertain significance (Jul 13, 2021) | ||
3-73384121-G-A | Likely benign (Oct 01, 2022) | |||
3-73384123-G-A | not specified | Uncertain significance (Apr 24, 2024) | ||
3-73384173-G-A | not specified | Uncertain significance (Oct 22, 2021) | ||
3-73384233-G-T | not specified | Uncertain significance (Aug 16, 2021) | ||
3-73384234-A-T | not specified | Uncertain significance (Aug 16, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
PDZRN3 | protein_coding | protein_coding | ENST00000263666 | 10 | 242508 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.985 | 0.0153 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.00506 | 623 | 623 | 1.00 | 0.0000410 | 6941 |
Missense in Polyphen | 188 | 219.42 | 0.85679 | 2365 | ||
Synonymous | -2.02 | 322 | 279 | 1.15 | 0.0000219 | 2050 |
Loss of Function | 4.68 | 5 | 34.7 | 0.144 | 0.00000157 | 443 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.0000473 | 0.0000462 |
European (Non-Finnish) | 0.0000978 | 0.0000967 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: E3 ubiquitin-protein ligase. Plays an important role in regulating the surface level of MUSK on myotubes. Mediates the ubiquitination of MUSK, promoting its endocytosis and lysosomal degradation. Might contribute to terminal myogenic differentiation. {ECO:0000250|UniProtKB:Q69ZS0}.;
Recessive Scores
- pRec
- 0.133
Intolerance Scores
- loftool
- 0.280
- rvis_EVS
- -0.99
- rvis_percentile_EVS
- 8.63
Haploinsufficiency Scores
- pHI
- 0.472
- hipred
- Y
- hipred_score
- 0.768
- ghis
- 0.575
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.741
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Pdzrn3
- Phenotype
- growth/size/body region phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype;
Gene ontology
- Biological process
- neuromuscular junction development;protein ubiquitination
- Cellular component
- nucleus;nucleoplasm;cytosol;cell junction;neuromuscular junction
- Molecular function
- ubiquitin-protein transferase activity;zinc ion binding;ubiquitin protein ligase activity